Search results
Neurocrine Biosciences' Huntington's disease drug gets FDA approval
Reuters via AOL· 49 minutes agoHuntington's disease is an inherited condition that causes the progressive breakdown of nerve cells in the brain, resulting in a gradual decline in motor control, cognition ...
It’s Been a Long Time Coming – FDA’s Final Rule on Regulation of Laboratory Developed Tests (LDTs)...
The National Law Review· 5 hours agoToday, on April 29, 2024, following more than a decade of discourse, the U.S. Food and Drug...
FDA approves Neurocrine Biosciences' Huntington's disease drug
Reuters via Yahoo Finance· 50 minutes agoApril 30 (Reuters) - The U.S. Food and Drug Administration (FDA) has approved granule formulation of Neurocrine Biosciences' drug to treat movement disorders ...
E. coli outbreak: Walnuts sold in at least 19 states linked to illnesses in California and...
USA TODAY via Yahoo News· 6 minutes agoThe expiration dates are from May 21, 2025 to June 7, 2025. The walnuts' lot codes are 3325-043 and...
FDA finalizes lab test regulations with more flexibility
Politico· 6 hours agoDiana DeGette (D-Colo.) and Larry Bucshon (R-Ind.) — co-sponsors of legislation known as the VALID Act — said that while they are disappointed with the rule, they “recognize that FDA ...
FDA finalizes rule to increase oversight of lab tests
Boston Herald· 4 hours agoThe rule effectively reclassifies tests developed and performed in a lab as medical devices for the...
Federal authorities seize more than $700K in illegal e-cigarette products in California
UPI· 3 hours ago"Removing unauthorized tobacco products from the supply chain is one of many enforcement tools we...
FDA Issues Final Rule on Regulation of Laboratory Developed Tests | JD Supra
JD Supra· 15 hours agoApril 29, 2024, the U.S Food and Drug Administration (FDA) announced its final rule on Laboratory Developed Tests (LDTs). This final ruling amends the & ...
Pfizer and Genmab’s Tivdak wins full FDA approval for cervical cancer
Pharmaceutical Technology via Yahoo Finance· 8 hours agoThe BLA was accepted with priority review in April 2021 and approved in September 2021. The FDA’s...
FDA Finally Moves to Scrutinize Specialized Health Screenings
ProPublica· 4 hours ago“This is a significant step forward,” said Peter Lurie, president and executive director of the...